How many institutions held PASG - Passage BIO, Inc. - Common Stock, par value $0.0001 per share in Q2 2020?

66 institutional investors reported PASG - Passage BIO, Inc. - Common Stock, par value $0.0001 per share for Q2 2020. Use the holders table for investor-level position and value details.

Passage BIO, Inc. - Common Stock, par value $0.0001 per share (PASG)

Q: What does CUSIP 702712100 represent in this 13F holders report?

CUSIP 702712100 is the security identifier for PASG - Passage BIO, Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

CUSIP: 702712100

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class: Equity / Common Stock, par value $0.0001 per share
Shares outstanding: 3,182,163
Total 13F shares: 31,598,964
Share change: +2,447,006
Total reported value: $862,660,732
Price per share: $27.33
Number of holders: 66
Value change: +$80,586,836
Number of buys: 42
Number of sells: 24

Quarterly Holders Quick Answers

What is CUSIP 702712100?
CUSIP 702712100 identifies PASG - Passage BIO, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2020
Previous quarter: Q1 2020

Recent filing periods for CUSIP 702712100:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

Top shareholders of PASG - Passage BIO, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
ORBIMED ADVISORS LLC	13F	Company	219%	6,962,899	$109,666,000	—	31 Mar 2020	13F
FRAZIER MANAGEMENT LLC	13F	Company	157%	5,009,219	$78,895,000	—	31 Mar 2020	13F
FMR LLC	13F	Company	98%	3,134,124	$49,363,000	—	31 Mar 2020	13F
New Leaf Venture Partners, L.L.C.	13F	Company	78%	2,497,922	$39,342,000	—	31 Mar 2020	13F
Vivo Capital, LLC	13F	Company	70%	2,229,587	$35,116,000	—	31 Mar 2020	13F
Boxer Capital, LLC	13F	Company	59%	1,883,315	$29,662,000	—	31 Mar 2020	13F
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	21%	670,367	$10,558,000	—	31 Mar 2020	13F
BlackRock Finance, Inc.	13F	Company	19%	619,787	$9,762,000	—	31 Mar 2020	13F
Logos Global Management LP	13F	Company	19%	603,338	$8,960,000	—	31 Mar 2020	13F
ALKEON CAPITAL MANAGEMENT LLC	13F	Company	16%	505,000	$7,953,000	—	31 Mar 2020	13F
SPHERA FUNDS MANAGEMENT LTD.	13F	Company	15%	478,171	$7,135,000	—	31 Mar 2020	13F
Alyeska Investment Group, L.P.	13F	Company	13%	408,161	$6,429,000	—	31 Mar 2020	13F
HIGHLINE CAPITAL MANAGEMENT, L.P.	13F	Company	12%	369,332	$5,817,000	—	31 Mar 2020	13F
EMERALD ADVISERS, LLC	13F	Company	11%	354,601	$5,585,000	—	31 Mar 2020	13F
RA CAPITAL MANAGEMENT, L.P.	13F	Company	10%	322,630	$5,081,000	—	31 Mar 2020	13F
EMERALD MUTUAL FUND ADVISERS TRUST	13F	Company	10%	321,013	$5,056,000	—	31 Mar 2020	13F
MORGAN STANLEY	13F	Company	9.2%	292,642	$4,609,000	—	31 Mar 2020	13F
BAKER BROS. ADVISORS LP	13F	Company	8.6%	275,000	$4,331,000	—	31 Mar 2020	13F
HHLR ADVISORS, LTD.	13F	Company	7.9%	250,616	$3,947,000	—	31 Mar 2020	13F
Artal Group S.A.	13F	Company	7.9%	250,000	$3,938,000	—	31 Mar 2020	13F
Rock Springs Capital Management LP	13F	Company	7.1%	225,000	$3,544,000	—	31 Mar 2020	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	6.6%	209,310	$3,297,000	—	31 Mar 2020	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	6.1%	194,288	$3,060,000	—	31 Mar 2020	13F
Weiss Multi-Strategy Advisers LLC	13F	Company	5.7%	179,796	$2,832,000	—	31 Mar 2020	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	5.1%	163,853	$2,581,000	—	31 Mar 2020	13F
Atom Investors LP	13F	Company	4.7%	150,000	$2,363,000	—	31 Mar 2020	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	4%	128,028	$2,016,000	—	31 Mar 2020	13F
GOLDMAN SACHS GROUP INC	13F	Company	3.9%	123,200	$1,940,000	—	31 Mar 2020	13F
ArrowMark Colorado Holdings LLC	13F	Company	1.9%	62,000	$977,000	—	31 Mar 2020	13F
Marshall Wace North America L.P.	13F	Company	1.9%	61,248	$965,000	—	31 Mar 2020	13F
CAAS CAPITAL MANAGEMENT LP	13F	Company	1.6%	50,000	$788,000	—	31 Mar 2020	13F
FEDERATED HERMES, INC.	13F	Company	1.3%	40,000	$630,000	—	31 Mar 2020	13F
Cinctive Capital Management LP	13F	Company	0.68%	21,486	$338,000	—	31 Mar 2020	13F
NORGES BANK	13F	Company	0.63%	20,000	$315,000	—	31 Mar 2020	13F
HSBC HOLDINGS PLC	13F	Company	0.46%	14,500	$228,000	—	31 Mar 2020	13F
CITADEL ADVISORS LLC	13F	Company	0.4%	12,730	$200,000	—	31 Mar 2020	13F
Blackstone Inc.	13F	Company	0.38%	12,000	$189,000	—	31 Mar 2020	13F
VANGUARD GROUP INC	13F	Company	0.36%	11,437	$181,000	—	31 Mar 2020	13F
TD ASSET MANAGEMENT INC	13F	Company	0.33%	10,493	$165,000	—	31 Mar 2020	13F
Maven Securities LTD	13F	Company	0.33%	10,400	$164,000	—	31 Mar 2020	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.25%	7,942	$125,000	—	31 Mar 2020	13F
Pinz Capital Management, LP	13F	Company	0.13%	4,250	$67,000	—	31 Mar 2020	13F
CITIGROUP INC	13F	Company	0.04%	1,127	$18,000	—	31 Mar 2020	13F
NewSquare Capital LLC	13F	Company	0.03%	1,000	$16,000	—	31 Mar 2020	13F
Tower Research Capital LLC (TRC)	13F	Company	0%	146	$2,000	—	31 Mar 2020	13F

Institutional Holders of Passage BIO, Inc. - Common Stock, par value $0.0001 per share (PASG) as of Q2 2020

As of 30 Jun 2020, Passage BIO, Inc. - Common Stock, par value $0.0001 per share (PASG) was held by 66 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 31,598,964 shares. The largest 10 holders included ORBIMED ADVISORS LLC, FRAZIER MANAGEMENT LLC, FMR LLC, New Leaf Venture Partners, L.L.C., Vivo Capital, LLC, BOXER CAPITAL, LLC, BlackRock Inc., HIGHLINE CAPITAL MANAGEMENT, L.P., VANGUARD GROUP INC, and ALKEON CAPITAL MANAGEMENT LLC. This page lists 66 institutional shareholders reporting positions in this security for the Q2 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2020 vs Q1 2020 Across Filers

Q1 2020 holders

Q2 2020 holders

Holder diff

Investor	Q1 2020 Shares	Q2 2020 Shares	Share Diff	Share Chg %	Q1 2020 Value $	Q2 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.